Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy

Abstract

These advantages underline the potential of autologous patient-derived NExT to revolutionize tailored adoptive cancer nanotherapy and chemoimmunotherapy, which endorses their widespread clinical application of autologous patient-derived NExT.